A bright future for bioluminescent imaging in viral research

Future Virology

Volumn 10, Issue 2, 2015, Pages 169-183

  Coleman, Stewart M ^a   McGregor, Alistair ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

bioluminescence imaging; BLI; CCD camera; cytomegalovirus; herpes simplex; influenza; luciferase; pathogenesis; viral dissemination; virus imaging

Indexed keywords

ANTIVIRUS AGENT; LUCIFERASE; LUCIFERIN; ONCOLYTIC VIRUS;

BIOLUMINESCENCE; BIOLUMINESCENCE IMAGING; CAMERA; CHARGE COUPLED CAMERA; CYTOMEGALOVIRUS; DENGUE VIRUS; EBOLA VIRUS; ENZYME SUBSTRATE; FILOVIRUS; GAMMAHERPESVIRINAE; HERPES SIMPLEX VIRUS 1; HIGH THROUGHPUT SCREENING; HUMAN CYTOMEGALOVIRUS; IMAGE ANALYSIS; IN VIVO STUDY; INFLUENZA VIRUS A; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LATENT PERIOD; MONKEYPOX VIRUS; NONHUMAN; OPTICS; PICORNAVIRIDAE; POXVIRIDAE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REAL TIME TRACKING SYSTEM; REPORTER GENE; REVIEW; TRANSGENIC MOUSE; VARICELLA ZOSTER VIRUS; VIRAL GENE THERAPY; VIRAL TROPISM; VIROLOGY; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS REACTIVATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALIA; CYTOMEGALOVIRUS; MUS;

EID: 84923303591     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.14.96     Document Type: Review

References (106)

1. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed. Opt. 10(4), 41210 (2005).
2. Contag CH, Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4, 235-260 (2002).
3. Tannous B, A. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat. Protoc. 4, 582-591 (2009).
4. Wurdinger T. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat. Methods 5, 171-173 (2008).
5. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17(5), 545-580 (2003).
6. Burgos JS, Guzman-Sanchez F, Sastre I, Fillat C, Valdivieso F. Non-invasive bioluminescence imaging for monitoring herpes simplex virus type 1 hematogenous infection. Microbes Infect. 8(5), 1330-1338 (2006).
7. Thorne SH. Design and testing of novel oncolytic vaccinia strains. Methods Mol. Biol. 542, 635-647 (2009).
8. Luker GD, Bardill JP, Prior JL, Pica CM, Piwnica-Worms D, Leib DA. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J. Virol. 76(23), 12149-12161 (2002).
9. Luker GD, Prior JL, Song J, Pica CM, Leib DA. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J. Virol. 77(20), 11082-11093 (2003).
10. Pasieka TJ, Collins L, O'connor MA et al. Bioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in alphassgamma interferon receptor-deficient mice. PLoS ONE 6(9), e24018 (2011).
11. Luker KE, Schultz T, Romine J, Leib DA, Luker GD. Transgenic reporter mouse for bioluminescence imaging of herpes simplex virus 1 infection in living mice. Virology 347(2), 286-295 (2006).
12. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81(13), 7011-7021 (2007).
13. Mutnal MB, Hu S, Lokensgard JR. Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus. PLoS ONE 7(3), e33143 (2012).
14. De Wet JR, Wood KV, Helinski DR, Deluca M. Cloning of firefly luciferase cDNA and the expression of active luciferase in Escherichia coli. Proc. Natl Acad. Sci. USA 82(23), 7870-7873 (1985).
15. Lembert N, Idahl LA. Regulatory effects of ATP and luciferin on firefly luciferase activity. Biochem. J. 305(Pt 3), 929-933 (1995).
16. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc. Natl Acad. Sci. USA 99(1), 377-382 (2002).
17. Stacer AC, Nyati S, Moudgil P et al. NanoLuc reporter for dual luciferase imaging in living animals. Mol. Imaging 12(7), 1-13 (2013).
18. Villalobos V, Naik S, Bruinsma M et al. Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem. Biol. 17(9), 1018-1029 (2010).
19. Yoshimitsu M, Sato T, Tao K et al. Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proc. Natl Acad. Sci. USA 101(48), 16909-16914 (2004).
20. Evans MS, Chaurette JP, Adams ST, Jr et al. A synthetic luciferin improves bioluminescence imaging in live mice. Nat. Methods 11(4), 393-395 (2014).
21. Fan X, Ren P, Dhal S et al. Noninvasive monitoring of placenta-specific transgene expression by bioluminescence imaging. PLoS ONE 6(1), e16348 (2011).
22. Branchini BR, Ablamsky DM, Murtiashaw MH, Uzasci L, Fraga H, Southworth TL. Thermostable red and green light-producing firefly luciferase mutants for bioluminescent reporter applications. Anal. Biochem. 361(2), 253-262 (2007).
23. Zhao H, Doyle TC, Wong RJ et al. Characterization of coelenterazine analogs for measurements of Renilla luciferase activity in live cells and living animals. Mol. Imaging 3(1), 43-54 (2004).
24. Kim SB, Suzuki H, Sato M, Tao H. Superluminescent variants of marine luciferases for bioassays. Anal. Chem. 83(22), 8732-8740 (2011).
25. Loening AM, Wu AM, Gambhir SS. Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat. Methods 4(8), 641-643 (2007).
26. Tannous BA. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat. Protoc. 4(4), 582-591 (2009).
27. Wurdinger T, Badr C, Pike L et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat. Methods 5(2), 171-173 (2008).
28. Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P. In vivo bioluminescent imaging of influenza A virus infection and characterization of novel cross-protective monoclonal antibodies. J. Virol. 87(15), 8272-8281 (2013).
29. Maguire CA, Bovenberg MS, Crommentuijn MH et al. Triple bioluminescence imaging for in vivo monitoring of cellular processes. Mol. Ther. Nucleic Acids 2, e99 (2013).
30. Wendt MK, Molter J, Flask CA, Schiemann WP. In vivo dual substrate bioluminescent imaging. J. Vis. Exp. (56), e3245 (2011).
31. Cronin M, Akin AR, Collins SA et al. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting. PLoS ONE 7(1), e30940 (2012).
32. Hall MP, Unch J, Binkowski BF et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 7(11), 1848-1857 (2012).
33. Kuo C, Coquoz O, Troy TL, Xu H, Rice BW. Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. J. Biomed. Opt. 12(2), 024007 (2007).
34. Lu Y, Machado HB, Bao Q, Stout D, Herschman H, Chatziioannou AF. In vivo mouse bioluminescence tomography with radionuclide-based imaging validation. Mol. Imaging Biol. 13(1), 53-58 (2011).
35. Feng. J, Qin C, Jia K, Zhu S, Yang X, Tian J. Bioluminescence tomography imaging in vivo: recent advances. J. Sel. Topics Quant. Electr. 18(4), (2012).
36. Bray M, Lawler J, Paragas J, Jahrling PB, Mollura DJ. Molecular imaging of influenza and other. emerging respiratory viral infections. J. Infect. Dis. 203(10), 1348-1359 (2011).
37. In vivo imaging technology. www.perkinelmer.com
38. Berthold. www.berthold.com/en
39. Photometrics. www.photometrics.com
40. Li-Cor Biosciences. http://licor.com
41. Spectral Instruments. www.specimg.com
42. TriFoil Imaging. www.trifoilimaging.com
43. Bruker. www.bruker-preclinical.com
44. Luker KE, Luker GD. Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res. 78(3), 179-187 (2008).
45. Zeamari S, Rumping G, Floot B, Lyons S, Stewart FA. In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. Br. J. Cancer 90(6), 1259-1264 (2004).
46. Mcgregor A, Mcvoy M A, Schleiss MR. The guinea pig model of congenital cytomegalovirus infection. In: Cytomegaloviruses. Reddehase M J (Ed.). Caister Academic Press, Norfolk, UK, 88-118 (2013).
47. Karlsson EA, Meliopoulos VA, Tran V, Mehle A, Schultz-Cherry S. Real-time in vivo imaging of influenza virus transmission dynamics in ferrets. Presented at: American Society for Virology 33rd Annual Meeting. Fort Collins, CO, USA, 21-25 June 2014.
48. Edinger M, Cao YA, Hornig YS et al. Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur. J. Cancer 38(16), 2128-2136 (2002).
49. Curtis A, Calabro K, Galarneau JR, Bigio IJ, Krucker T. Temporal variations of skin pigmentation in C57BL/6 mice affect optical bioluminescence quantitation. Mol. Imaging Biol. 13(6), 1114-1123 (2011).
50. O'neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT. Bioluminescent imaging: a critical tool in pre-clinical oncology research. J. Pathol. 220(3), 317-327 (2010).
51. Berger F, Paulmurugan R, Bhaumik S, Gambhir SS. Uptake kinetics and biodistribution of 14C-D-luciferin-a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging. Eur. J. Nucl. Med. Mol. Imaging 35(12), 2275-2285 (2008).
52. Inoue Y, Kiryu S, Izawa K, Watanabe M, Tojo A, Ohtomo K. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging. Eur. J. Nucl. Med. Mol. Imaging 36(5), 771-779 (2009).
53. Keyaerts M, Remory I, Caveliers V et al. Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging. PLoS ONE 7(1), e30061 (2012).
54. Aswendt M, Adamczak J, Couillard-DespRes S, Hoehn M. Boosting bioluminescence neuroimaging: an optimized protocol for brain studies. PLoS ONE 8(2), e55662 (2013).
55. Hildebrandt IJ, Su H, Weber WA. Anesthesia and other considerations for in vivo imaging of small animals. ILAR J. 49(1), 17-26 (2008).
56. Cook SH, Griffin DE. Luciferase imaging of a neurotropic viral infection in intact animals. J. Virol. 77(9), 5333-5338 (2003).
57. Summers BC, Leib DA. Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters. J. Virol. 76(14), 7020-7029 (2002).
58. Murphy AA, Rosato PC, Parker ZM, Khalenkov A, Leib DA. Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging. Virology 444(1-2), 71-79 (2013).
59. Pasieka TJ, Menachery VD, Rosato PC, Leib DA. Corneal replication is an interferon response-independent bottleneck for virulence of herpes simplex virus 1 in the absence of virion host shutoff. J. Virol. 86(14), 7692-7695 (2012).
60. Zhang Z, Selariu A, Warden C et al. Genomewide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS Pathog. 6, e1000971 (2010).
61. Zhang Z, Huang Y, Zhu H. A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J. Virol. Methods 148(1-2), 197-204 (2008).
62. Zhang Z, Rowe J, Wang W et al. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J. Virol. 81(17), 9024-9033 (2007).
63. Zerboni L, Arvin A. Investigation of varicellazoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts. J. NeuroVirol. 17(6), 570-577 (2011).
64. Hwang S, Wu TT, Tong LM et al. Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo. J. Virol. 82(24), 12498-12509 (2008).
65. Reese TA, Wakeman BS, Choi HS et al. Coinfection. Helminth infection reactivates latent gamma-herpes virus via cytokine competition at a viral promoter. Science 345(6196), 573-577 (2014).
66. Marquardt A, Halle S, Seckert CK et al. Single cell detection of latent cytomegalovirus reactivation in host tissue. J. Gen. Virol. 92(Pt 6), 1279-1291 (2011).
67. Luker KE, Hutchens M, Schultz T, Pekosz A, Luker GD. Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread. Virology 341(2), 284-300 (2005).
68. Rivera R, Hutchens M, Luker KE, Sonstein J, Curtis JL, Luker GD. Murine alveolar macrophages limit replication of vaccinia virus. Virology 363(1), 48-58 (2007).
69. Hutson CL, Lee KN, Abel J et al. Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak. Am. J. Trop. Med. Hyg. 76(4), 757-768 (2007).
70. Falendysz EA, Londono-Navas AM, Meteyer CU et al. Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging. J. Wildl. Dis. 50(3), 524-536 (2014).
71. Osorio JE, Iams KP, Meteyer CU, Rocke TE. Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging. PLoS ONE 4(8), e6592 (2009).
72. Tran V, Moser LA, Poole DS, Mehle A. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J. Virol. 87(24), 13321-13329 (2013).
73. Li XF, Deng. YQ, Zhao H et al. Noninvasive bioluminescence imaging of dengue virus infection in the brain of A129 mice. Appl. MicroBiol. Biotechnol. 97(10), 4589-4596 (2013).
74. Schoggins JW, Dorner M, Feulner M et al. Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc. Natl Acad. Sci. USA 109(36), 14610-14615 (2012).
75. WHO. Ebola virus disease update-West Africa (2014). www.who.int
76. Uebelhoer LS, Albarino CG, Mcmullan LK et al. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses. Antiviral Res. 106, 86-94 (2014).
77. Hoenen T, Groseth A, Callison J, Takada A, Feldmann H. A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. Antiviral Res. 99(3), 207-213 (2013).
78. Mcgregor A, Choi KY. Cytomegalovirus antivirals and development of improved animal models. Expert Opin. Drug Metab. Toxicol. 7(10), 1245-1265 (2011).
79. Nakayama E, Saijo M. Animal models for Ebola and Marburg virus infections. Front. MicroBiol. 4, 267 (2013).
80. Deroose CM, Reumers V, Gijsbers R et al. Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging. Mol. Ther. 14(3), 423-431 (2006).
81. Dorner M, Horwitz JA, Robbins JB et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 474(7350), 208-211 (2011).
82. Johnson M, Huyn S, Burton J, Sato M, Wu L. Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Hum. Gene Ther. 17(12), 1262-1269 (2006).
83. Niu G, Xiong Z, Cheng. Z et al. In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Mol. Imaging Biol. 9(3), 126-134 (2007).
84. Franceschi V, Stellari FF, Mangia C et al. In vivo image analysis of BoHV-4-based vector in mice. PLoS ONE 9(4), e95779 (2014).
85. Msaouel P, Opyrchal M, Domingo Musibay E, Galanis E. Oncolytic measles virus strains as novel anticancer agents. Expert Opin. Biol. Ther. 13(4), 483-502 (2013).
86. Kuruppu D, Brownell AL, Shah K, Mahmood U, Tanabe KK. Molecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability. Cancer Res. 74(15), 4111-4121 (2014).
87. Lun X, Ruan Y, Jayanthan A et al. Doubledeleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors. Mol. Oncol. 7(5), 944-954 (2013).
88. Sugiyama T, Yoneda M, Kuraishi T et al. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment. Gene Ther. 20(3), 338-347 (2013).
89. LPTA Models. www.taconic.com/find-your-model
90. Lienenklaus S, Cornitescu M, Zietara N et al. Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J. Immunol. 183(5), 3229-3236 (2009).
91. Branchini BR, Southworth TL, Khattak NF, Michelini E, Roda A. Red-and greenemitting firefly luciferase mutants for bioluminescent reporter applications. Anal. Biochem. 345(1), 140-148 (2005).
92. Loening AM, Dragulescu-Andrasi A, Gambhir SS. A red-shifted Renilla luciferase for transient reporter-gene expression. Nat. Methods 7(1), 5-6 (2010).
93. Degeling MH, Bovenberg MS, Lewandrowski GK et al. Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability. Anal. Chem. 85(5), 3006-3012 (2013).
94. Bovenberg MS, Degeling MH, Hejazi S et al. Multiplex blood reporters for simultaneous monitoring of cellular processes. Anal. Chem. 85(21), 10205-10210 (2013).
95. Branchini BR, Ablamsky DM, Rosenberg JC. Chemically modified firefly luciferase is an efficient source of near-infrared light. Bioconjug. Chem. 21(11), 2023-2030 (2010).
96. Morse D, Tannous BA. A water-soluble coelenterazine for sensitive in vivo imaging of coelenterate luciferases. Mol. Ther. 20(4), 692-693 (2012).
97. Reddy GR, Thompson WC, Miller SC. Robust light emission from cyclic alkylaminoluciferin substrates for firefly luciferase. J. Am. Chem. Soc 132(39), 13586-13587 (2010).
98. Kheirolomoom A, Kruse DE, Qin S et al. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J. Control. Release 141(2), 128-136 (2010).
99. Conley NR, Dragulescu-Andrasi A, Rao J, Moerner WE. A selenium analogue of firefly D-luciferin with red-shifted bioluminescence emission. Angew. Chem. Int. Ed. Engl. 51(14), 3350-3353 (2012).
100. Kojima R, Takakura H, Ozawa T, Tada Y, Nagano T, Urano Y. Rational design and development of near-infrared-emitting firefly luciferins available in vivo. Angew. Chem. Int. Ed. Engl. 52(4), 1175-1179 (2013).
101. Xu T, Ripp S, Sayler GS, Close DM. Expression of a humanized viral 2A-mediated lux operon efficiently generates autonomous bioluminescence in human cells. PLoS ONE 9(5), e96347 (2014).
102. Billerbeck E, Horwitz JA, Labitt RN et al. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J. Immunol. 191(4), 1753-1764 (2013).
103. Massoud TF, Paulmurugan R, Gambhir SS. Molecular imaging of homodimeric protein-protein interactions in living subjects. FASEB J 18(10), 1105-1107 (2004).
104. Wang L, Fu Q, Dong Y et al. Bioluminescence imaging of Hepatitis C virus NS3/4A serine protease activity in cells and living animals. Antiviral Res. 87(1), 50-56 (2010).
105. Fu Q, Duan X, Yan S et al. Bioluminescence imaging of caspase-3 activity in mouse liver. Apoptosis 18(8), 998-1007 (2013).
106. Scabini M, Stellari F, Cappella P, Rizzitano S, Texido G, Pesenti E. In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation. Apoptosis 16(2), 198-207 (2011).